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Background and Objective. The aim of this study was to assess the subjective outcome following laparoscopic sacropexy. Methods.
We performed a retrospective cohort study among women treated for descensus with laparoscopic sacropexy between January
2000 and December 2007. 310 patients received questionnaires during followup assessing major pre- and postoperative symptoms
and overall satisfaction. Results. 214 (69%) patients responded to the questionnaire. Mean followup was 24.5 months. The number
of patients with back or lower abdominal pain, foreign body sensation in the vagina and prolapse-related symptoms, urinary
symptoms, vaginal and bladder infections, and the need for pessary usage decreased signiﬁcantly postsurgically. Bowel symptoms
increased slightly but not signiﬁcantly. Two years after surgery, nearly 2 thirds of the women were satisﬁed or very satisﬁed with
the outcome. Conclusion. Laparoscopic sacropexy is an eﬀective treatment of descensus, with favorable or satisfactory subjective
outcomes.
1.Introduction
Pelvicorganprolapseishighlyprevalentinwomen(30–50%)
[1], with a lifetime risk of surgical repair of 11% [2]. It is
associated with high costs for its treatment and a signiﬁcant
drop of women’s quality of life and serious discomfort [3].
The cause of prolapse is not known, but risk factors include
age, increasing number of gravidity and (especially) vaginal
deliveries,obesity,chroniccough,constipation,andahistory
of hysterectomy [1, 4]. Associated symptoms are amongst
urinary and fecal incontinence, vaginal ulceration, problems
with defecation, and sexual dysfunction [1].
Often pelvic symptoms and the extent of prolapse are
weaklycorrelated [5, 6].Womenwhoaremost impaired seek
surgical solutions. The main intention of surgery is to relieve
or improve prolapse symptoms and, if possible, associated
urinary and bowel symptoms. There are numerous surgical
procedures available for genital prolapse. The success rate
of laparoscopic sacropexy has been reported by a number
of authors to be 90–98% [7–10], but only a few studies
have evaluated the success of prolapse surgery by means of
patients’reportedsymptomsandsatisfaction.Theaimofthis
study was to analyze the subjective outcome of laparoscopic
sacropexy.
2.MaterialandMethods
A retrospective study was performed including all patients
undergoing laparoscopic sacropexy as treatment for descen-
sus between January 2000 and December 2007 at the “Klinik
f¨ ur Minimal Invasive Chirurgie” (Berlin). In this period,
310 patients underwent 310 primary sacropexies and 13
recurrentinterventions. Data were received from the medical
ﬁles of the patients and through evaluation of a patient
questionnaire.
Preoperative data included age, body mass index (BMI),
menopausal status, parity, the classiﬁcation of the patient
in accordance with the American Society of Anesthesiolo-
gists (ASA) score (I-IV), the classiﬁcation of pelvic organ
prolapse in accordance with the DGGG guidelines issued
by the German Association for Gynecology and Obstetrics2 Obstetrics and Gynecology International
[11], descensus of the anterior and posterior compartment,
history of previous gynecological operations, and respective
leading symptoms. It was also documented to what extent
additional surgical interventions became necessary during
laparoscopic sacropexy.
The indication for laparoscopic surgery as well as for
simultaneous surgery, depending on concomitant diseases,
was set by the respective surgeon in the pre-operative
consultation. Simultaneous operations were not considered
as exclusion criteria.
2.1. Presurgical Preparations. No laxative preparation was
done. On induction of anesthesia, the urinary bladder was
catheterized, and, after vaginal disinfection, dressing forceps
with a ﬁxed swab were inserted into the vagina.
Ten patients (3.2%) were permanently catheterized due
to additional vaginal treatments. A total of 46 patients
(14.2%) prophylactically received one dose of 1.5g ampi-
cillin/sulbactam intraoperative and postoperative.
2.2. Surgical Technique. In laparoscopic sacropexy according
toRaatz, asit is performedat theKlinik f¨ urMinimal Invasive
Chirurgie (Clinic for Minimal Invasive Surgery) in Berlin
since 2000, the repositioning of the prolapsed anatomical
structures is accomplished by employing a prolene mesh.
The mesh is attached to either the prolapsed vaginal stump
or the posterior cervical wall, in case of uterus prolapse
and its planned preservation or to the cervical stump—
followingsupracervicalhysterectomy.Aftertherepositioning
of the prolapsed structures, the mesh is attached to the
promontorium.
Afterbladdercatheterismandvaginaldisinfection,dress-
ing forceps with a ﬁxed swab are inserted into the vagina
at the beginning of the operation. With the patient in
horizontal position, with stretched legs, a CO2 pneumoperi-
toneum is established utilizing a Veress needle. A 5-mm
transumbilical trocar is used for the laparoscopy with
5mm/30◦ optics. Then the patient is placed in maximum
(steep)Trendelenburg’sposition.Thelaparoscopicsacropexy
thenrequiresonlytwomore5mmpuncturesitesinthelower
abdomen. The left incision is made lateral to the epigastric
vessels above the pubic hair line on the left side, while the
right trocar is inserted considerably higher, that is, lateral to
the promontorium or even slightly higher.
In order to improve the exposure of the promontorium,
it may be helpful to position the patient slightly to the left,
or to remove the sigma from the operating area through a
restraining suture on the mesosigma. In case of an existing
right adnexa, this may also be temporarily removed from
the operating area by using a PDS sling. After exposure
and palpation of the promontorium using grasping forceps,
bleeding is controlled by bipolar coagulation, and the
peritoneum is opened up using scissors. On the right side,
the ureter and the lateral iliac vessels should be exposed in
order to prevent injuries.
The peritoneum is opened up along the right pelvic
wall while special caution must be observed regarding the
ureter and the vessels of the mesosigma up to the cervix or
the vaginal stump, respectively. The The right sacrouterine
ligament serves as an orientation mark; that is, the peri-
toneum is opened up at the upper edge of the ligamentum
sacrouterinum up to the cervix, after which the peritoneum
is partially dissected from the posterior cervical wall.
After the peritoneum is opened up above the promonto-
rium, the presacral fat tissue is loosened and removed from
the Os sacrum using atraumatic grasping forceps on the left
and bipolar grasping forceps on the right side. This mostly
takes place rather bluntly and must be done very carefully, in
order to not rupture any vessels. This way, the ﬂat surface of
the ligamentum longitudinale becomes visible bit by bit.
At this point, it is of utmost importance to avoid a lesion
of the median sacral artery. An about 8–10cm long, and 1.5–
2-cm-wide strip of the prolene mesh (SURGIPRO Mesh) is
then inserted into the abdomen. To this end, the atraumatic
grasping forceps are moved in an outward direction above
the 5mm trocar, after the valve of the trocar has been
removed earlier.
The mesh is then grasped outside the abdominal cavity
and is pulled into the abdominal cavity via the 5mm trocar
while still folded together. This is followed by the ﬁxation
of the mesh on the cervical stump. The mesh is attached
on broadbase to the cervix through a continuous suture.
This suture requires several stiches into and out of the
cervix and the mesh. The mesh is then ﬁxated by tying
several knots. Alternatively, ﬁxation is also possible through
simple interrupted stiches. We mostly use a POLYSORB
1. Then follows the insertion of a second thread and
needle (ETHIBOND 0). The ligamentum longitudinale is
exposed once more. This usually requires holding aside the
peritoneum or intestine with the grasping forceps.
On the right, the needle is clamped in the needle
holder, and a Z-suture is stitched onto the ligamentum
longitudinale. It must be ensured that the distance between
stiches on the ligamentum longitudinale is suﬃciently wide
so that the mesh does not rip oﬀ after ﬁxation.
The swab placed in the vagina beforehand is then used
to move the cervix from a vaginal position to a position
above the levator plate. The atraumatic grasping forceps
are used to pull the mesh cranially along the Z-suture on
the ligamentum longitudinale. The mesh is then stitched
several times in line with the promontorium and tied to the
ligamentum longitudinale.
Excess parts of the mesh and thread are cut oﬀ and
disposedof.Thenfollowstheperitonealizationofthecervical
stump and the mesh through a continuous suture. This
technique of sacropexy may be carried out on the posterior
cervical wall in case of uterus preservation, on the vaginal
stump in case of previous hysterectomy, or, as described,
on the cervical stump during or after a supracervical
hysterectomy. Fixation on the vaginal stump takes place after
previous preparation at the posterior vaginal wall. However,
while pushing up the vaginal stump, with the swab inside
the vagina, it must be ensured that the needle does not
grasp the swab and stitch it to the surface. In case of uterus
preservation, the mesh is ﬁxated on the posterior cervical
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2.3. Questionnaire. Follow-up data were collected through a
self-administeredquestionnaireduringpostoperativefollow-
up. All patients received a questionnaire 6 months after
surgery at the earliest. The questionnaire used in this study
was composed of diﬀerent international questionnaires, for
example, the Pelvic Floor Distress Inventory and Pelvic
Floor Impact Questionnaire of Life [13–15]. It included
questions on parity (number of children, method of deliv-
ery), preoperative menopausal status, following gynecologic
surgeries (number and which kind of surgery: laparoscopy,
laparotomy, bladder surgery, surgery on the ureter, vagi-
nal surgery on the pelvic ﬂoor), and preoperative and
postoperative symptoms as lower abdominal pain (staging:
mild, medium, severe, very severe), defecation problems
(constipation, pain during defecation, fecal incontinence),
foreign body sensation in the vagina, dyspareunia, urine
incontinence symptoms, voiding diﬃculties, micturition
problems (frequent micturition (more than 3 times a day)),
frequent urgency, prolapse-related symptoms, vaginal and
bladder infections, back pain, pessary usage. Furthermore,
postsurgical changes in frequency of sex, willingness to be
examined again by the same surgeon, and overall satisfaction
(staging:notsatisﬁed,partlysatisﬁed,satisﬁed,verysatisﬁed)
were evaluated.
2.4. Statistical Analysis. A l la n a l y s e sw e r ep e r f o r m e dw i t h
software packages Exel (Microsoft, Redmond, USA) and
the Statistical Package for the Social Sciences (Windows
version 15.0; SPSS Inc, Chicago [IL], US). Continuous
data were recorded as mean values and standard deviation;
the conﬁdence interval was determined using the t-test.
Statistical signiﬁcance was demonstrated using the paired-
sample Wilcoxon’s rank test. The signiﬁcance level was set at
a P v a l u eo fl e s st h a n0 . 0 5 .
3. Results
3.1. Demographic Data. From January 2000 to December
2007, 310 women suﬀering from descensus underwent
laparoscopic surgery at the “Klinik f¨ ur Minimal Invasive
Chirurgie” (Berlin). Table 1 shows preoperative demo-
graphic and clinical characteristics of the study population.
In the study group, mean parity was 1.85. 64.6% of
women were multipara. 92.6% of the children were delivered
spontaneously, 2.8% were given birth by forceps delivery or
vacuum extraction; respectively, and 1.7% caesarian sections
were performed.
Regarding previous gynecologic operations, 43 patients
(13.9%) had undergone previous pelvic ﬂoor repair surgery
because of pelvic organ prolapse. In all cases, vaginal
surgeries were performed. 25.5% (79 patients) had previ-
ously undergone a hysterectomy (50 vaginal hysterectomies,
18 laparoscopic supracervical hysterectomies (LASH), 11
abdominal hysterectomies). Out of 50 vaginal hysterec-
tomies, 20 surgeries were performed in combination with
colporrhaphy, of which were 13 anterior, 6 posterior col-
porrhaphies, and 1 simultaneous anterior and posterior
colporrhaphy. 4 vaginal sacrospinal ﬁxations, 5 surgeries for
Table 1: Preoperative characteristics of the study population.
Study group (n = 310)
Age (yrs, mean ± SD, range) 56.7 ±10.2 (33–81)
Body mass index (kg/m2, mean + SD) 25.2 ±3.51
Menopause (n, %) 159 (51.4)
ASA (n,% )
ASA I 73 (23.5)
ASA II 135 (43.5)
ASA III 100 (32.3)
ASA IV 2 (0.6)
descensus (n,% )
Stage I 73 (23.5)
Stage II 158 (51)
Stage III 76 (24.5)
Stage IV 3 (1)
Additional descensus (n, %)
Anterior compartment 112 (35.1)
Posterior compartment 48 (15.5)
Urinary symptoms (n, %) 164 (52.9)
Stress incontinence 75 (45.7)
Urge incontinence 6 (3.6)
Mixed incontinence 10 (6.1)
No clear diagnosis 73 (44.5)
O t h e rs y m p t o m s( n,% )
Pressure on bladder 39 (12.6)
Pressure pain in vaginal area 133 (42.9)
Dyspareunia 23 (7.4)
Lower back pain 100 (32.3)
Pressure downwards directed 161 (51.9)
urine incontinence, including 1 Burch-colposuspension, and
4 tension-free vaginal tape (TVT) operations, were done
previously.
3.2. Operative Procedures. 213 (68.7%), 67 (21.6%), and
30 (9.7%) patients had undergone sacropexy with mesh
attachment to the cervix, to the apex of the vagina and to
the uterus, respectively.
Concomitant surgeries were necessary for 270 patients
(87.1%).Additionallytolaparoscopicsacropexy,195patients
(62.9%) had undergone a LASH, 5 patients (1.6%) had
undergone a vaginal hysterectomy, and 1 patient (0.3%)
had undergone a laparoscopic vaginal hysterectomy (LAVH).
Additionally, 96 adnectomies (31%), 19 salpingectomies
(6.1%), 124 bowel and omental adhesiolyses (40%), 5
anterior (1.6%), and 6 posterior (1.9%) colporrhaphies were
performed. Twelve women received a TVT, and 30 patients
(9.6%) had had ovarian cyst removal surgery.
3.3. Residual Operations. Of 323 total sacropexies, thir-
teen resacropexies (4.0%) were performed. Seven (3.6%)
sacropexies with cervical mesh attachment, 4 sacropexies4 Obstetrics and Gynecology International
with mesh attachment to the apex vaginae (6%), and 2
sacropexies with mesh attachment to the uterus (6.7%)
needed to be operated. In 1 case, a re-resacropexy was
necessary after mesh ripping on the distal pole two months
after residual operation. Indications for reoperations were
descensus level IV in 6 cases (41.7%) and descensus level III
in 7 cases (58.3%). Eight surgeries were performed without
concomitantintervention;5resacropexieswereaccompanied
by simultaneous surgeries.
3.4. Questionnaire. Out of 310 patients, 214 patients
responded to the questionnaire. Mean time between surgery
and answering the questionnaire was 24.5 ± 19.9 months
(95% CI 21.6; 27.1, Min/Max 6 months/82 months). Pre-
and postoperative results of the questionnaire are presented
in Tables 2 and 3.
In sum, 24.7% of the patients subjectively suﬀered
from persistent symptoms 24.5 months after surgery. A
signiﬁcant reduction (P<0.05) after surgery was detected
for occurrence of back pain, symptomatic foreign body
sensation in the vagina and prolapse-related symptoms,
urine incontinence and disturbances of bladder functions
like feeling of residual urine and voiding diﬃculties, the
number of vaginal and bladder infections, and the need for
pessary usage. Symptoms concerning defecation increased
slightly but not signiﬁcantly after surgery.
49 patients (out of 202) suﬀered from preoperative
sexualimpairment,and33patientsdecidedfortheoperation
because of this symptom. While symptoms improved for 39
patients, 6 patients reported an aggravation of symptoms.
Of 194 patients, 21.1% reported a change in frequency of
sex after surgery, from which 47.1% indicated a reduced and
52.9% an increased frequency of sex. For 78.9% surgery did
not inﬂuence the frequency of sex. Reduction in frequency of
sex correlated with the age of the patients.
After sacropexy, lower abdominal pain and pain severity
were reduced signiﬁcantly (P<0.05).
In 48 out of 214 patients (22.4%), additional descen-
sus surgeries were necessary during followup. In sum, 66
surgeries, including 9 laparoscopies, 2 laparotomies, 11
bladder surgeries, 7 intestine surgeries, 1 ureter surgery, 14
transvaginal pelvic ﬂoor surgeries, and 22 other inventions,
were done.
Two years after surgery, nearly two-thirds of the women
were satisﬁed or very satisﬁed with the outcome, and less
than 10% were not satisﬁed (see Table 4).
No correlation was found between severity of descensus
and postoperative satisfaction. No signiﬁcant diﬀerence
of satisfaction depending on mesh attachment point was
found. Satisfaction correlated with the need for follow-up
intervention.
4. Discussion
As the correlation between many pelvic symptoms and the
extent of prolapse is weak [5, 6], the success of prolapse
surgery should not only be assessed by objective outcome
but by subjective evaluation through the patient. Subjective
Table 2: Symptoms, preoperative and followup.
n = 214 Preoperative (n, %) Followup (n,% )
Back pain 117 (54.6) 97 (45.3)
Pain in the lower abdomen 72 (33.6) 41 (19.5)
Defecation problems 59 (27.5) 69 (32.2)
Constipation 46 (21.5) 52 (24.3)
Pain during defecation 9 (4.2) 14 (6.5)
Fecal incontinence 7 (3.3) 10 (4.6)
Foreign body sensation in
vagina 118 (55.1) 13 (11)
Prolapse-related symptoms 177 (82.7) 49 (22.8)
Dyspareunia 49 (24.3) 10 (5)
Urine incontinence 139 (65.3) 89 (41.5)
Feeling of residual urine 69 (32.2) 41 (19.1)
Voiding diﬃculties 43 (20.6) 24 (11.5)
Vaginal infections 31 (14.5) 14 (6.5)
Bladder infection 33 (15.4) 19 (8.8)
Need for pessary usage 20 (9.3) 8 (3.7)
Table 3: Lower abdominal pain, preoperative and followup.
n = 214 Preoperative (n, %) Followup (%)
Pain, total 72 (100%) 41 (100%)
Mild 15 (20.8%) 17 (41.4%)
Medium 24 (33.3%) 16 (39%)
Severe 25 (34.7%) 8 (19.5%)
Very severe 8 (11.1%) 0
success of prolapse surgery is determined by the absence of
symptoms. Prolapse causes various and mainly undeﬁned
symptoms of urinary, anorectal, and coital nature. In our
study, urinary incontinence, defecation problems, dyspare-
unia, and foreign body sensation in the vagina/prolapse-
related symptoms were identiﬁed as leading symptoms. By
means of these symptoms, subjective success of laparoscopic
sacropexy was assessed using a self-administered question-
naire.
With the exception of bowel symptoms, a signiﬁcant
postoperative reduction of all assessed symptoms was
observed, irrespective of the mesh attachment point (cervix,
uterus, vaginal apex). The rate of persistence was the highest
for back pain (82.9%) and among the lowest for prolapse-
related symptoms like feeling of downward pressure (27.7%)
and foreign body sensation in the vagina (11%). Only 40%
of the women in need for a pessary were still using it
after surgery. The number of patients being aﬀected by
vaginal and bladder infections decreased from 31 (14.5%)
and 33 (15.4%) patients to 14 (6.5%) and 19 (8.8%)
patients postoperatively, respectively. After sacropexy, lower
abdominal pain and pain severity were reduced signiﬁcantly
(P<0.05).
The number of patients suﬀering from fecal inconti-
nence, constipation, and pain during defecation increased
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attachment point. Whereas Bradley et al. [16] showed a
statistically signiﬁcant improvement of obstructive defeca-
tory and other bowel symptoms after prolapse surgery and
especially after sacropexy, Nygaard et al. [17] did not report
improvement of bowel functions. Also, for the symptom
constipation—before and after sacropexy—diﬀerent results
exist in the literature. Whereas Baessler and Schuessler [18]
found signiﬁcant improvement of constipation, Maher et
al. [19] found no signiﬁcant diﬀerence. This might indicate
that other pathologic conditions besides rectocele inﬂuence
bowel functions. This is also indicated by our ﬁnding
that positive answers concerning defecation problems did
not correlate with the extent of rectoceles in some cases,
evaluated in postoperative followup. While 12 patients with
postoperative rectocele report no defecation problems, 21
patients with no diagnosed rectocele suﬀer from defecation
problems. However, these ﬁndings have to be interpreted
carefully, as postoperative examination was 7.8 months and
followup 24.5 months [20].
Furthermore, the correlation of the severity of bowel
symptoms and of vaginal prolapse is discussed controver-
sially. Weber et al. [21] found a weak correlation between
bowel symptoms and severity of vaginal prolapse, whereas
Meschia et al. [22] found a 2-fold increased risk of fecal
incontinence in patients with a rectocele greater than grade
II. In general, posterior procedures for rectocele repair in
addition to sacropexy increase the risk of new bowel symp-
toms, including fecal incontinence with physical activity and
pain prior to and during defecation [16, 23].
The number of patients with urinary incontinence,
voiding diﬃculties, and feeling of residual urine decreased
signiﬁcantly postsurgically. But still about 60% of our
patients showed persistent urinary symptoms. Higgs et
al. [10] reported no change of urinary symptoms for
half of their study population, and only 12% showed no
urinary symptoms after surgery. Postoperative feeling of
residual urine and voiding diﬃculties might be caused by
a hypocontractile bladder due to sympathicus stimulation,
as a result from surgical trauma [24]. These ﬁndings have
important implications for counseling and treatment of
patients regarding the prognosis of urinary and bowel
symptoms after prolapse surgery.
The number of patients suﬀering from dyspareunia
decreased signiﬁcantly postoperatively with a persistence
rate of 20%, supporting other studies [19, 25, 26]. Our
study reports a higher success rate in resolved dyspareunia.
Whereas preoperative dyspareunia was resolved in 79.6% of
our patients; in the literature 58.4% [26] and 56% [19]w e r e
reportedafterabdominalsacropexy.Thismightbeduetothe
operative technique, in which, on the one hand, the mesh is
extraperitonealized, and on the other hand, due to the swab
inserted into the vagina, the sutures do not push the net too
far into the vaginal area. What is more, the vagina is ﬁxated
almost in good axial alignment, so it is only slightly moved
laterally (preferably right-laterally, so as to gain distance to
the Sigmoid colon).
In our study, we found a reduced sexual activity after
surgery, correlating with age which is contrary to previous
data which show an improved sexual activity irrespective of
Table 4: Postoperative satisfaction.
n = 214 Patients (n,% )
Not satisﬁed 21 (9.8)
Partly satisﬁed 53 (24.7)
Satisﬁed 59 (27.6)
Very satisﬁed 81 (37.9)
age [25]. While 47.1% of the patients indicated a reduced
frequency of sex; 11.4% and 41.4% of the patients reported
an increased frequency or no changes after surgery in our
study.
In total, 24.7% of the patients suﬀered from recurrent
symptoms 24.5 months after surgery, whereas an objective
success rate of 96% according to the reoperation rate or
89.6% according to the persistence/recurrence prolapse
assessment 7.9 months after surgery was reported for the
same study population [20]. These data are comparable with
the literature. Higgs et al. [10] reported recurrent/persistent
urinary and bowel symptoms in 38% of patients 66 months
after surgery. Rozet et al. [27] reported a symptomatic cure
rate of 96% whereas 85% were anatomically cured.
Anatomical correction of the pelvic ﬂoor often does
not correlate with subjective symptoms. Still nearly three-
thirds of all patients were satisﬁed or very satisﬁed with the
treatment outcome 2 years after surgery.
There are a few limitations to our study. The percentage
of followup loss was quite high with only 214 patients (69%)
responding to the questionnaire. It is possible that mainly
unsatisﬁed patients did not attend the followup which leads
to falsiﬁed positive results. However, we assume the risk to
be little as our data concerning symptoms and satisfaction
are comparable to the literature. Our study is further limited
by the fact that answers to the questionnaires were given
i nr e t r o s p e c t .I ti sa s s u m e dt h a ts o m ep a t i e n t sp o t e n t i a l l y
embellish situations when asked to answer a question in
retrospect, and, therefore, it is believed that retrospective
studies attract and receive lower levels of participation.
The third drawback of this study was the use of a
non-validated symptoms questionnaire. Instead of using
validated questionnaires, we tried to assess surgery outcome
by symptoms according to speciﬁc deﬁnitions or criteria.
In future large population-based long-term follow-up
studies, which focus on prolapse symptoms, using disease-
speciﬁc validated questionnaires are necessary to draw a
more deﬁnite conclusion about the subjective outcome of
prolapse surgery.
5. Conclusion
Laparoscopic sacropexy is an eﬃcient treatment for genital
prolapse. We show a subjective success rate of 85.3% 24.5
months after surgery. With the exception of bowel symp-
toms, a signiﬁcant postoperative reduction of all assessed6 Obstetrics and Gynecology International
symptoms was observed irrespective of the mesh attachment
point. The high rate of persistent urinary and bowel symp-
toms requires special counseling and treatment for aﬀected
women.
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